Evidence map›Paper›PMID 17369290›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2007

A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Chirag Kariya, Heather Leitner, Elysia Min, Christiaan van Heeckeren, Anna van Heeckeren, Brian J Day

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function.Metabolomics : Official journal of the Metabolomic Society · 2021
    Article
  7. Article
  8. Response to Letter to the Editor from Dr. Guilford.European journal of nutrition · 2015
    Article
  9. Redox balance in cystic fibrosis.The international journal of biochemistry & cell biology · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Glutathione deficient C57BL/6J mice are not sensitized to ozone-induced lung injury.Biochemical and biophysical research communications · 2010
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chirag KariyaDepartment of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, Denver, Colorado, USA.
Heather Leitner
Elysia Min
Christiaan van Heeckeren
Anna van Heeckeren
Brian J Day
National Jewish Health · USCase Western Reserve University · USUniversity of Colorado Denver · USUniversity of Colorado Health · US

Funding

Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
Adaptive glutathione responses to cigarette smoke in COPDR01HL084469 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2008 to 2011
$1.6M
Glutathione transport, oxidative stress and lung injuryR01HL075523 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2004 to 2007
$1.3M
NHLBI NIH HHS HL-075523NHLBI NIH HHS R01 HL075523NHLBI NIH HHS R01 HL084469NIDDK NIH HHS P30 DK027651NIDDK NIH HHS P30-DK-027651
6 · The paper itself

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) protein is the only known apical glutathione (GSH) transporter in the lung. The purpose of these studies was to determine whether oral GSH or glutathione disulfide (GSSG) treatment could increase lung epithelial lining fluid (ELF) GSH levels and whether CFTR plays a role in this process. The pharmacokinetic profile of an oral bolus dose of GSH (300 mg/kg) was determined in mice. Plasma, ELF, bronchoalveolar lavage (BAL) cells, and lung tissue were analyzed for GSH content. There was a rapid elevation in the GSH levels that peaked at 30 min in the plasma and 60 min in the lung, ELF, and BAL cells after oral GSH dosing. Oral GSH treatment produced a selective increase in the reduced and active form of GSH in all lung compartments examined. Oral GSSG treatment (300 mg/kg) resulted in a smaller increase of GSH levels. To evaluate the role of CFTR in this process, Cftr knockout (KO) mice and gut-corrected Cftr KO-transgenic (Tg) mice were given an oral bolus dose of GSH (300 mg/kg) and compared with wild-type mice for changes in GSH levels in plasma, lung, ELF, and BAL cells. There was a twofold increase in plasma, a twofold increase in lung, a fivefold increase in ELF, and a threefold increase in BAL cell GSH levels at 60 min in wild-type mice; however, GSH levels only increased by 40% in the plasma, 60% in the lung, 50% in the ELF, and twofold in the BAL cells within the gut-corrected Cftr KO-Tg mice. No change in GSH levels was observed in the uncorrected Cftr KO mice. These studies suggest that CFTR plays an important role in GSH uptake from the diet and transport processes in the lung.

Indexed as

Administration, OralAnimalsBronchoalveolar Lavage FluidCystic Fibrosis Transmembrane Conductance RegulatorGlutathioneIntestinal AbsorptionLungMaleMiceMice, Inbred C57BLMice, Inbred CFTRMice, KnockoutCystic Fibrosis Transmembrane Conductance RegulatorGlutathione

Identifiers

PMID17369290
PMCPMC3983954
OpenAlexW2152040872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.